Breaking News Instant updates and real-time market news.

WDAY

Workday

$144.07

-1.85 (-1.27%)

14:25
10/02/18
10/02
14:25
10/02/18
14:25

Workday to host analyst day

Analyst Day to be held in Las Vegas on October 2 at 5:30 pm. Webcast Link

  • 02

    Oct

WDAY Workday
$144.07

-1.85 (-1.27%)

09/11/18
WBLR
09/11/18
NO CHANGE
WBLR
HR service delivery market is accelerating, says William Blair
William Blair analyst Justin Furby spent time researching the human resource service delivery sector and believes the market "remains in the early innings of adoption." Spending on HR service delivery applications has significant growth potential over the next several years, Furby tells investors in a research note. He thinks that over the last 9 to 12 months, there appears to be a "clear acceleration" in activity levels in the HR service delivery market. He estimates the annual HR service delivery application opportunity is $1.4B in the U.S. and $2B-$3B globally. Both ServiceNow (NOW) and Ultimate Software (ULTI) appear well positioned to participate in the growth of HR service delivery applications, and though competitive dynamics "are likely to heat up over time," the market can support more than one growth story, contends Furby. Further, he expects expect Workday (WDAY) "to enter the discussion over time." The analyst has Outperform ratings on all three names.
09/05/18
BARD
09/05/18
NO CHANGE
Target $169
BARD
Outperform
Workday shares continue to have significant upside runway, says Baird
Baird analyst Mark Marcon noted Workday exceeded Q2 expectations and provided better than expected guidance. The analyst said the company continues to gain market share and its core offerings continue to experience solid traction with a good pipeline for the second half. Marcon continues to recommend disciplined accumulation as the company continues to have a significant runway. Marcon reiterated his Buy rating and raised his price target to $169 from $140 on Workday shares.
09/05/18
BMOC
09/05/18
NO CHANGE
Target $165
BMOC
Market Perform
Workday price target raised to $165 from $137 at BMO Capital
BMO Capital analyst Keith Bachman raised his price target on Workday to $165 after its "solid if unspectacular" Q2 results, saying the company's billings were largely in line and revenues just slightly above consensus. The analyst expects the stock price advance to take a "short-term pause" after its strong performance year-to-date but to remain supported in the long-term based on the company's fundamentals. Bachman also keeps his Market Perform rating on Workday, adding that its "valuation appears high".
09/05/18
ADAM
09/05/18
NO CHANGE
Target $175
ADAM
Buy
Workday price target raised to $175 from $145 at Canaccord
Canaccord analyst Richard Davis raised his price target on Workday to $175 from $145 following solid Q2 results. The analyst noted the stock was down after hours but said he is confident in 5-10 years from now the company will be a much bigger, higher margin and presumably more valuable business. Davis reiterated his Buy rating on Workday shares.

TODAY'S FREE FLY STORIES

09:45
10/23/18
10/23
09:45
10/23/18
09:45
Hot Stocks
Breaking Hot Stocks news story  »

Bio Rad Laboratories…

TSLA

Tesla

$263.12

2.09 (0.80%)

09:45
10/23/18
10/23
09:45
10/23/18
09:45
Hot Stocks
Citron reverses opinion on Tesla, goes long shares into earnings »

Citron Research, best…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

09:45
10/23/18
10/23
09:45
10/23/18
09:45
General news
U.S. Richmond Fed index preview: »

U.S. Richmond Fed index…

09:45
10/23/18
10/23
09:45
10/23/18
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

October Richmond Fed…

VFC

VF Corp.

$77.62

(0.00%)

09:43
10/23/18
10/23
09:43
10/23/18
09:43
Recommendations
VF Corp. analyst commentary  »

VF Corp price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$95.61

(0.00%)

09:42
10/23/18
10/23
09:42
10/23/18
09:42
Technical Analysis
Technical Take: Market Vectors Semiconductor at new 52-week low, major top »

The Market Vectors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MA

MasterCard

$204.52

(0.00%)

09:40
10/23/18
10/23
09:40
10/23/18
09:40
Options
Unusually active option classes on open October 23rd »

Unusual total active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

HON

Honeywell

$152.63

-0.86 (-0.56%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Upgrade
Honeywell rating change  »

Honeywell upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTS

QTS Realty Trust

$40.40

-0.59 (-1.44%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Upgrade
QTS Realty Trust rating change  »

QTS Realty Trust upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 07

    Nov

EXPI

eXp World Holdings

$12.50

0.35 (2.88%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Hot Stocks
eXp Realty to acquire ShowMeNow, terms not disclosed »

eXp Realty, a subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TSLA

Tesla

$261.03

0.97 (0.37%)

09:38
10/23/18
10/23
09:38
10/23/18
09:38
Periodicals
Breaking Periodicals news story on Tesla »

Citron says long Tesla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

KOF

Coca-Cola Femsa

$59.41

-1.75 (-2.86%)

09:36
10/23/18
10/23
09:36
10/23/18
09:36
Upgrade
Coca-Cola Femsa rating change  »

Coca-Cola Femsa upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$47.93

0.34 (0.71%)

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Oracle initiated  »

Oracle initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 14

    Nov

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Conference/Events
JPMorgan European & EMEA analysts to hold analyst/industry conference call »

European Utilities…

ABBV

AbbVie

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
AbbVie initiated  »

AbbVie initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

SNY

Sanofi

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Sanofi initiated  »

Sanofi reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

RHHBY

Roche

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Roche initiated  »

Roche reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 24

    Dec

09:35
10/23/18
10/23
09:35
10/23/18
09:35
General news
Treasury 2-year auction outlook: the $38 B 2-year sale »

Treasury 2-year auction…

PFE

Pfizer

$44.37

-0.13 (-0.29%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Pfizer initiated  »

Pfizer reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 07

    Nov

GSK

GlaxoSmithKline

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
GlaxoSmithKline initiated  »

GlaxoSmithKline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

  • 07

    Nov

LLY

Eli Lilly

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Eli Lilly initiated  »

Eli Lilly reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

NVS

Novartis

$87.12

-0.07 (-0.08%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Novartis initiated  »

Novartis reinitiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MRK

Merck

$72.56

0.22 (0.30%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Merck initiated  »

Merck reinitiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

BMY

Bristol-Myers

$50.87

-3.44 (-6.33%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Bristol-Myers initiated  »

Bristol-Myers reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 29

    Oct

  • 07

    Nov

  • 20

    May

AZN

AstraZeneca

$39.50

0.295 (0.75%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
AstraZeneca initiated  »

AstraZeneca reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.